检索结果-南通市图书馆

Two elective invasive procedures after a single avatrombopag treatment in a patient with liver cirrhosis and severe thrombocytopenia

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Gastroenterology Report 2022年第1期10卷 668-670页

作者： Marco Biolato Federica Vitale giuseppe marrone Luca Miele Antonio Grieco Internal and Liver Transplant Medicine Unit CEMADDepartment of Medical and Surgical SciencesFondazione Policlinico Universitario Agostino Gemelli IRCCSRomeItaly Institute of Internal Medicine Catholic University of the Sacred HeartRomeItaly

Introduction Severe thrombocytopenia(platelet count56×10^(9)/L[2].Observational studies found that severe thrombocytopenia may be predictive of post-procedure bleeding after liver biopsy,dental extractions,percutaneo... 详细信息

关键词： treatment cirrhosis liver

Branched chain amino acids in hepatic encephalopathy and sarcopenia in liver cirrhosis:Evidence and uncertainties

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2023年第19期29卷 2905-2915页

作者： giuseppe marrone Amato Serra Luca Miele Marco Biolato Antonio Liguori Antonio Grieco Antonio Gasbarrini Medical and Surgical Sciences Fondazione Policlinico Universitario A.Gemelli-IRCCSUniversita Cattolica del Sacro CuoreRome 00168Italy

Liver cirrhosis is commonly associated with nutritional alterations,reported in 20% of patients with compensated disease and over 60% of patients with decompensated *** disturbances are associated with a worse prognosis and increased risk of *** levels of branched-chain amino acids(BCAAs)are decreased in patients with liver *** imbalance of amino acids levels has been suggested to be associated with the development of complications,such as hepatic encephalopathy and sarcopenia,and to affect the clinical presentation and prognosis of these *** studies investigated the efficacy of BCAAs supplementation as a therapeutic option in liver cirrhosis,but uncertainties remain about the real efficacy,the best route of administration,and dosage.

关键词： Branched-chain amino acids Hepatic encephalopathy Sarcopenia Liver cirrhosis

Disseminated intravascular coagulation after splenic artery aneurysm coils embolization:an unexpected surprise

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

Gastroenterology Report 2023年第1期11卷 551-553页

作者： Marco Biolato Alessandro D’Errico Fiammetta Maria Rognoni giuseppe marrone Luca Laurenti Alessandro Cina Antonio Grieco Department of Medical and Surgical Sciences Fondazione Policlinico Universitario Agostino Gemelli IRCCSRomeItaly Institute of Internal Medicine Catholic University of the Sacred HeartRomeItaly Department of Diagnostic imaging Radiation oncology and HematologyFondazione Policlinico Universitario Agostino Gemelli IRCCSRomeItaly Institute of Hematology Catholic University of the Sacred HeartRomeItaly Institute of Radiology Catholic University of the Sacred HeartRomeItaly

Introduction The Society for Vascular Surgery recommends treating nonruptured splenic artery aneurysms(SAAs)of>3 cm with a demonstrable increase in size or with associated symptoms[1].Percutaneous intervention with embolization coils or covered stents has become popular due to its high technical success rates and low morbidity[2,3].

关键词： Surgery artery coils

Direct oral anticoagulant administration in cirrhotic patients with portal vein thrombosis:What is the evidence?

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Hepatology 2022年第4期14卷 682-695页

作者： Marco Biolato Mattia Paratore Luca Di Gialleonardo giuseppe marrone Antonio Grieco Internal and Liver Transplant Medicine Unit CEMADDepartment of Medical and Surgical SciencesFondazione Policlinico Universitario Agostino Gemelli IRCCSRome 00168Italy Institute of Internal Medicine Catholic University of Sacred HeartRome 00168Italy

In recent years,the traditional concept that cirrhosis-related coagulopathy is an acquired bleeding disorder has ***,it is known that in cirrhotic patients,the hemostatic system is rebalanced,which involves coagulation factors,fibrinolysis and *** alterations disrupt homeostasis,skewing it toward a procoagulant state,which can lead to thromboembolic manifestations,especially when hemodynamic and endothelial factors co-occur,such as in the portal vein system in *** vein thrombosis is a common complication of advanced liver cirrhosis that negatively affects the course of liver disease,prognosis of cirrhotic patients and success of liver *** is still debated whether portal vein thrombosis is the cause or the consequence of worsening liver *** therapy is the mainstay treatment for acute symptomatic portal vein *** chronic portal vein thrombosis,the role of anticoagulant therapy is still *** anticoagulants,vitamin K antagonists and low-molecular-weight heparin are standard-of-care treatments for portal vein *** the last ten years,direct oral anticoagulants have been approved for the prophylaxis and treatment of many thromboembolicrelated diseases,but evidence on their use in cirrhotic patients is very *** aim of this review was to summarize the evidence about the safety and effectiveness of direct oral anticoagulants for treating portal vein thrombosis in cirrhotic patients.

关键词： Dabigatran Rivaroxaban Apixaban Edoxaban Bleeding

Intestinal permeability in the pathogenesis of liver damage: From non-alcoholic fatty liver disease to liver transplantation

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2019年第33期25卷 4814-4834页

作者： Alberto Nicoletti Francesca Romana Ponziani Marco Biolato Venanzio Valenza giuseppe marrone Gabriele Sganga Antonio Gasbarrini Luca Miele Antonio Grieco Fondazione Policlinico Universitario A Gemelli IRCCS Rome 00168Italy UniversitàCattolica del Sacro Cuore Rome 00168Italy

The intimate connection and the strict mutual cooperation between the gut and the liver realizes a functional entity called gut-liver *** integrity of intestinal barrier is crucial for the maintenance of liver *** this mutual relationship,the liver acts as a second firewall towards potentially harmful substances translocated from the gut,and is,in turn,is implicated in the regulation of the *** evidence has highlighted the relevance of increased intestinal permeability and consequent bacterial translocation in the development of liver *** particular,in patients with non-alcoholic fatty liver disease recent hypotheses are considering intestinal permeability impairment,diet and gut dysbiosis as the primary pathogenic *** advanced liver disease,intestinal permeability is enhanced by portal *** clinical consequence is an increased bacterial translocation that further worsens liver ***,this pathogenic mechanism is implicated in most of liver cirrhosis complications,such as spontaneous bacterial peritonitis,hepatorenal syndrome,portal vein thrombosis,hepatic encephalopathy,and hepatocellular *** liver transplantation,the decrease in portal pressure should determine beneficial effects on the gut-liver axis,although are incompletely understood data on the modifications of the intestinal permeability and gut microbiota composition are still *** the modulation of the intestinal permeability could prevent the initiation and progression of liver disease is still an uncovered area,which deserves further attention.

关键词： Bacterial translocation Gut microbiota Gut-liver axis Liver disease Cirrhosis Mediterranean diet Personalized medicine

Intestinal permeability after Mediterranean diet and low-fat diet in non-alcoholic fatty liver disease

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2019年第4期25卷 509-520页

作者： Marco Biolato Fiorella Manca giuseppe marrone Consuelo Cefalo Simona Racco Giacinto A Miggiano Venanzio Valenza Antonio Gasbarrini Luca Miele Antonio Grieco Department of Gastroenterological Endocrine-Metabolic and Nefro-Urological Sciences Fondazione Policlinico Universitario A. Gemelli IRCCS Institute of Special Medical Pathology and Medical Semeiotics Università Cattolica del Sacro Cuore Institute of Internal Medicine and Geriatrics Università Cattolica del Sacro Cuore Department of Image Diagnostics Oncological Radiotherapy and Hematology Sciences Fondazione Policlinico Universitario A. Gemelli IRCCS Nuclear Medicine Institute Università Cattolica del Sacro Cuore

BACKGROUND In non-alcoholic fatty liver disease(NAFLD), a high-fat or high-fructose diet increases intestinal permeability and promotes derangement of the gut-liver *** hypothesize that, diet could be able to modulate intestinal permeability in patients with *** To detect diet-induced modification of intestinal permeability in patients with NAFLD undergoing a Mediterranean diet or a low-fat *** The current study was a dietary intervention for non-diabetic, patients with biopsy-verified NAFLD and increased transaminases. A crossover design was employed: participants underwent 16 weeks of Mediterranean diet, 16 wk of free wash-out, and 16 weeks of low-fat diet. Both diets were hypocaloric and no consumption of supplements was allowed. All patients were followed bimonthly by a dietitian. Evaluations of clinical and metabolic parameters were completed at baseline and at the end of each dietary period. Intestinal permeability was assessed by chromium-51 ethylene diamine tetraacetate excretion testing(51 CrEDTA).RESULTS Twenty Caucasian patients, 90% male, median age 43 years, body mass index(BMI) 30.9, with biopsy-verified NAFLD were enrolled. At the end of 16 weeks of a Mediterranean diet, a significant reduction in mean body weight(-5.3 ± 4.1 kg,P = 0.003), mean waist circumference(-7.9 ± 4.9 cm, P = 0.001), and mean transaminase levels [alanine aminotransferase(ALT)-28.3 ± 11.9 IU/L, P =0.0001; aspartate aminotransferase(AST)-6.4 ± 56.3 IU/L, P = 0.01] were observed. These benefits were maintained after 16 wk of wash-out and also after16 wk of low-fat diet, without further improvements. Fourteen of the 20 patients had intestinal permeability alteration at baseline(mean percentage retention of51 Cr-EDTA = 5.4%), but no significant changes in intestinal permeability were observed at the end of the 16 wk of the Mediterranean diet or 16 wk of the low-fat *** Mediterranean diet is an effective strategy for treating overweight, visceral obesit

关键词： Liver steatosis Gut-liver axis Nutrition Personalized medicine Visceral obesity

Frequency of and reasons behind non-listing in adult patients referred for liver transplantation: Results from a retrospective study

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Transplantation 2024年第2期14卷 99-106页

作者： Marco Biolato Luca Miele giuseppe marrone Claudia Tarli Antonio Liguori Rosaria Calia Giovanni Addolorato Salvatore Agnes Antonio Gasbarrini Maurizio Pompili Antonio Grieco Department of Medical and Surgical Sciences CEMADFondazione Policlinico Universitario Agostino Gemelli IRCCSRome 00168Italy Department of Translational Medicine and Surgery Catholic University of Sacred HeartRome 00168Italy

BACKGROUND Few studies have evaluated the frequency of and the reasons behind the refusal of listing liver transplantation *** To assess the ineligibility rate for liver transplantation and its *** A single-center retrospective study was conducted on adult patients which entailed a formal multidisciplinary assessment for liver transplantation *** predictors for listing were evaluated using multivariable logistic *** In our center,314 patients underwent multidisciplinary work-up before liver transplantation enlisting over a three-year *** most frequent reasons for transplant evaluation were decompensated cirrhosis(51.6%)and hepatocellular carcinoma(35.7%).The non-listing rate was 53.8%and the transplant rate was 34.4%for the whole *** hundred and five motivations for ineligibility were *** most common contraindications were psychological(9.3%),cardiovascular(6.8%),and surgical(5.9%).Inappropriate or premature referral accounted for 76(37.1%)*** multivariable analysis,a referral from another hospital(OR:2.113;95%CI:1.259–3.548)served as an independent predictor of *** A non-listing decision occurred in half of our cohort and was based on an inappropriate or premature referral in one case out of *** referral from another hospital was taken as a strong predictor of non-listing.

关键词： Controindication Eligibility Evaluation Referral Personalized medicine

Reverse time-dependent effect of alphafetoprotein and disease control on survival of patients with Barcelona Clinic Liver Cancer stage C hepatocellular carcinoma

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Hepatology 2017年第36期9卷 1322-1331页

作者： Francesca Romana Ponziani Irene Spinelli Emanuele Rinninella Lucia Cerrito Antonio Saviano Alfonso Wolfango Avolio Michele Basso Luca Miele Laura Riccardi Maria Assunta Zocco Brigida Eleonora Annicchiarico Matteo Garcovich Marco Biolato giuseppe marrone Anna Maria De Gaetano Roberto Iezzi Felice Giuliante Fabio Maria Vecchio Salvatore Agnes Giovanni Addolorato Massimo Siciliano Gian Lodovico Rapaccini Antonio Grieco Antonio Gasbarrini Maurizio Pompili Department of Internal Medicine Gastroenterology and Hepatology Agostino Gemelli Hospital Department of Liver Transplant Surgery Agostino Gemelli Hospital Department of Oncology Gastroenterology and Hepatology Agostino Gemelli Hospital Department of Bioimaging and Radiological Sciences Agostino Gemelli Hospital Department of Hepatobiliary Surgery Agostino Gemelli Hospital Department of Pathology Agostino Gemelli Hospital

AIM To characterize the survival of cirrhotic patients with Barcelona Clinic Liver Cancer(BCLC) stage C hepatocellular carcinoma(HCC) and to ascertain the factors predicting the achievement of disease control(DC).METHODS The cirrhotic patients with BCLC stage C HCC evaluated by the Hepatocatt multidisciplinary group were subjected to the investigation. Demographic, clinical and tumor features, along with the best tumor response and overall survival were recorded. RESULTS One hundred and ten BCLC stage C patients were included in the analysis; the median overall survival was 13.4 mo(95%CI: 10.6-17.0). Only alphafetoprotein(AFP) serum level > 200 ng/m L and DC could independently predict survival but in a time dependent manner, the former was significantly associated with increased risk of mortality within the first 6 mo of follow-up(HR = 5.073, 95%CI: 2.159-11.916, P = 0.0002), whereas the latter showed a protective effect against death after one year(HR = 0.110, 95%CI: 0.038-0.314, P < 0.0001). Only patients showing microvascular invasion and/or extrahepatic spread recorded lower chances of achieving DC(OR = 0.263, 95%CI: 0.111-0.622, P = 0.002).CONCLUSION The BCLC stage C HCC includes a wide heterogeneous group of cirrhotic patients suitable for potentially curative treatments. The reverse and time dependent effect of AFP serum level and DC on patients' survival confers them as useful predictive tools for treatment management and clinical decisions.

关键词： Hepatocellular carcinoma Cirrhosis Barcelona Clinic Liver Cancer stage C Alphafetoprotein Disease control Performance status Survival

Multidisciplinary imaging of liver hydatidosis

在线全文

维普期刊数据库

学校读者我要写书评

暂无评论

World Journal of Gastroenterology 2012年第13期18卷 1438-1447页

作者： Gianluca marrone Francesca Crino' Settimo Caruso giuseppe Mamone Vincenzo Carollo Mariapina Milazzo Salvatore Gruttadauria Angelo Luca Bruno Gridelli Department of Diagnostic and Interventional Radiology Mediterranean Institute for Transplantation and Advanced Specialized TherapiesUniversity of Pittsburgh Medical Center Italy90127 PalermoItaly Department of Transplantation Surgery Mediterranean Institute for Transplantation and Advanced Specialized TherapiesUniversity of Pittsburgh Medical Center Italy90127 PalermoItaly

Liver hydatidosis is a parasitic endemic disease affecting extensive areas in our planet, a significant stigma within medicine to manage because of its incidence, possible complications, and diagnostic involvements. The diagnosis of liver hydatidosis should be as fast as possible because of the relevant complications that may arise with disease progression, involving multiple organs and neighboring structures causing disruption, migration, contamination. The aim of this essay is to illustrate the role of imaging as ultrasonography （US）, multi detector row computed tomography, and magnetic resonance imaging （MRI） in the evaluation of liver hydatidosis： the diagnosis, the assessment of extension, the identification of possible complications and the monitoring the response to therapy. US is the screening method of choice. Computed tomography （CT） is indi-cated in cases in which US is inadequate and has high sensitivity and specificity for calcified hydatid cysts. Magnetic resonance is the best imaging procedure to demonstrate a cystic component and to show a biliary tree involvement. Diagnostic tests such as CT and MRI are mandatory in liver hydatidosis because they allow thorough knowledge regarding lesion size, location, and relations to intrahepatic vascular and biliary structures, providing useful information for effective treatment and decrease in post-operative morbidity. Hydatid disease is classified into four types on the basis of their radiologic appearance.

关键词： Liver hydatidosis Hepatic cyst Daughtercysts Calcified cyst Pericyst